Bredis Healthcare

Developer of AI-powered diagnostic tools for Alzheimer's disease. This company develops and provides high-sensitivity biomarker tests and digital platforms for the early diagnosis, prevention, and management of Alzheimer

placeGuri Si, Gyeonggi Do, South Korea calendar_todayFounded 2023 groups8 employees language bredis.co.kr

Social engagement

Social engagement: 90 social following, 5 posts in the last 12 months — below the industry typical range.

Investor mix

3 investors on record; lead investors include KAIST Youth Startup Investment Holdings.

Investor typeCountShare
Venture capital133%
Private equity133%
Other / undisclosed133%

Recent activity

2 Jun 2026
Event
NeuroFrontiers 2026: Biomarkers and Next-Generation Diagnostics in Neurological Disorders
15 May 2026
Event
2026 Korean SocietY of Clinical Chemistry Spring Conference
Coming soon